Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYALGAN vs saline injections for Achilles tendinopathy
2013-004117-40Phase 3Terminated
- Sponsor
- Fidia Farmaceutici
- Start
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium hyaluronate in Achilles tendinitis (AT) (2 arms), sponsored by Fidia Farmaceutici. Primary endpoint: VISA-A score at day 28. Started Oct 2013; status: terminated.
02
Drugs
sodium hyaluronate
03
Conditions
Achilles tendinitis (AT)
Beyond the preview
Go deeper on 2013-004117-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004117-40.